IDENTIFICATION AND QUANTIFICATION OF POTENTIAL IMPURITIES USING LC-PDA COUPLED WITH NEW QDa MASS DETECTOR IN A NEW SINGLE TABLET REGIMEN CONTAINING DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN HIV-1 PREVENTION. Int. Res. J. Pharm. 2019;10(3):91-104. Accessed October 30, 2026. https://irjponline.org/index.php/irjp/article/view/315